Personalized Cytokine Management System
Legal Citation
Summary of the Inventive Concept
A next-generation system for detecting, preventing, and treating cytokine-related disorders, leveraging wearable devices, AI-driven profiling, and targeted micro-dosing to provide personalized care.
Background and Problem Solved
The original patent addressed the need for effective treatments of inflammatory disorders by inhibiting pro-inflammatory cytokine release. However, it relied on administering a fixed dose of the compound to subjects. The new inventive concept solves the problem of inadequate personalized treatment by integrating wearable devices, machine learning algorithms, and real-time micro-dosing to create a tailored approach for each individual.
Detailed Description of the Inventive Concept
The Personalized Cytokine Management System comprises four interconnected modules: 1) a wearable device that continuously monitors cytokine levels in the subject's blood; 2) a machine learning algorithm that analyzes the data to generate a unique cytokine profile for the subject; 3) a micro-dosing module that administers a customized amount of the compound: or a pharmaceutically acceptable salt thereof, based on the subject's profile; and 4) a user interface that provides real-time feedback and personalized recommendations for treatment. The system enables early detection of cytokine imbalances, prevents cytokine storms, and optimizes treatment outcomes.
Novelty and Inventive Step
The new inventive concept's novelty lies in its integration of wearable devices, AI-driven profiling, and real-time micro-dosing, which provides a paradigm shift in personalized cytokine management. The inventive step is the synergistic combination of these components, enabling a proactive, tailored approach to cytokine-related disorders.
Alternative Embodiments and Variations
Alternative embodiments may include the use of implantable devices, mobile apps, or cloud-based services to facilitate data analysis and treatment recommendations. Variations may involve the integration of additional biomarkers or the application of the system to other disease areas, such as cancer or autoimmune disorders.
Potential Commercial Applications and Market
The Personalized Cytokine Management System has significant commercial potential in the healthcare industry, particularly in the areas of precision medicine, wearable technology, and AI-driven diagnostics. The target market includes pharmaceutical companies, medical device manufacturers, and healthcare providers seeking to improve patient outcomes and reduce treatment costs.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology, specifically immunomodulatory drug delivery and cytokine management systems, requiring advanced knowledge of medical device design, machine learning, microfluidics, and pharmacological intervention strategies
Person of Ordinary Skill (PHOSITA) Profile
A professional with a PhD in biomedical engineering or pharmaceutical sciences, expertise in medical device design, proficiency in machine learning algorithms, understanding of cytokine biology, and experience with point-of-care diagnostic technologies
Obviousness Rationale
A PHOSITA would recognize that the personalized cytokine management system represents a predictable technological evolution of the source patent's core pharmaceutical intervention, applying known monitoring and data analysis techniques to enhance targeted drug delivery for inflammatory disorders. The integration of wearable sensing, AI-driven profiling, and micro-dosing represents a logical extension of existing medical technology frameworks for precision medicine. The technical variations demonstrate incremental improvements using standard engineering approaches to personalize pharmaceutical treatment strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,550 |
|---|---|
| Title | Benzathine analogs |
| Assignee(s) | UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, United States Government As Represented By The Department Of Veterans Affairs |